Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Mar 2005 08:51 AM
RNS
Additional Listing
10 Mar 2005 12:06 PM
RNS
Director Appt to UK Ventures
18 Feb 2005 08:52 AM
RNS
Provexis Reverse Takeover
11 Feb 2005 07:00 AM
RNS
New Venture Company
10 Feb 2005 01:30 PM
RNS
Holding(s) in Company
20 Jan 2005 07:01 AM
RNS
New Agreement
20 Jan 2005 07:00 AM
RNS
Interim Results
18 Jan 2005 07:00 AM
RNS
Launch of US Ventures
17 Jan 2005 10:47 AM
RNS
Associate Director Appointed
07 Jan 2005 10:44 AM
RNS
Notice of Results
21 Dec 2004 07:00 AM
RNS
Re Acolyte Biomedica
23 Sep 2004 02:25 PM
RNS
AGM Statement
22 Sep 2004 07:00 AM
RNS
Joint Venture
17 Aug 2004 07:00 AM
RNS
Final Results
11 Aug 2004 07:00 AM
RNS
Development Alliance
03 Aug 2004 02:15 PM
RNS
Collaboration Agreement
13 Jul 2004 07:00 AM
RNS
Contract Win
12 Jul 2004 07:00 AM
RNS
Notice of Results
07 Jul 2004 11:44 AM
RNS
Contract Extension
28 Jun 2004 07:00 AM
RNS
Appointment
27 Apr 2004 07:00 AM
RNS
Funding Contract
14 Apr 2004 07:00 AM
RNS
Provexis Completion of Trials
06 Apr 2004 07:00 AM
RNS
Completion of Disposal
23 Mar 2004 07:00 AM
RNS
Launch of MRSA Superbug Test
18 Mar 2004 08:18 AM
RNS
Disposal of Exago
17 Mar 2004 08:00 AM
RNS
First Day of Dealings

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100